Time Required to Dissolve Urate Deposits

ConditionGout
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Gout is characterized by episodes of acute arthritis of the lower limbs due to intermittent activation of innate immunity in the joints where urate crystals have formed. These crystals occur when serum urate (SUA) levels have been above 70 mg/L for many years. They can be dissolved by lowering SUA levels to at least 60 mg/L (treat-to-target - T2T - strategy). Once the crystals are dissolved, patients are no longer symptomatic and are considered to be in remission (treat-to-dissolve - T2D - strategy).

The presence of crystals and their dissolution during treatment can be monitored by repeated ultrasound (US) scans of the feet and knees.

The time required for complete dissolution varies from patient to patient. ReViGore40 is a cohort designed to i) determine the time to complete dissolution of urate deposits in joints when SUA levels are maintained below 40 mg/L, ii) determine the factors (clinical, biological, genetic) associated with the time required for complete dissolution of urate deposits within joints.

Eligibility criteria

Qualifiers

Age over 18 years

Gout according to the ACR/Eular 2015 criteria

SUA levels greater than 60 mg/L

US score (MTP1s, knees) ≥2/24

Disqualifiers

Ongoing urate lowering therapy

Severe and uncontrolled diseases such as cancer, cardiovascular or neurovegetative diseases

Pregnant or breast-feeding women

No affiliation to the French National Social Security System

Trial design

Treatments tested in this trial

  • Standard X-Rays
  • Ultrasound
  • DECT of feet
  • DNA sample
  • Serum collection

Treatment groups

250 Participants
are divided into 1 treatment group

Locations

1
APHP, Lariboisière Hospital, Rheumatology departement75010, Paris France

Sponsors and collaborators

Assistance Publique - Hôpitaux de Paris

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Collaborator

ART VIGGO Association for Research

Collaborator